Solventum Corporation (SOLV) Financials

SOLV Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 14.2 billion 9.4 billion
June 30, 2026 14.2 billion 9.4 billion
March 31, 2026 14.1 billion 9.1 billion
Dec. 31, 2025 14.3 billion 9.2 billion

SOLV Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 99.0 million 42.0 million
June 30, 2026 144.0 million 38.0 million
March 31, 2026 -273.0 million 51.0 million
Dec. 31, 2025 32.0 million 37.0 million

SOLV Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 -12.0 million
June 30, 2026 92.0 million
March 31, 2026 13.0 million
Dec. 31, 2025 63.0 million

SOLV Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 451.0 million 4.6 billion 206.0 million
June 30, 2026 403.0 million 4.6 billion 207.0 million
March 31, 2026 561.0 million 4.6 billion 207.0 million
Dec. 31, 2025 878.0 million 5.0 billion -

SOLV Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 170.8 million
June 30, 2026 174.4 million
March 31, 2026 175.5 million
Dec. 31, 2025 175.3 million

SOLV Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 80.0 million 181.0 million 813.0 million -
June 30, 2026 83.0 million 178.0 million 927.0 million -
March 31, 2026 84.0 million 189.0 million 827.0 million -
Dec. 31, 2025 63.0 million 176.0 million 759.0 million -

SOLV Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 1.9 billion 887.0 million
June 30, 2026 2.2 billion 923.0 million
March 31, 2026 2.0 billion 910.0 million
Dec. 31, 2025 2.0 billion 1.0 billion

SOLV Revenue by Segment

Graph available only for paid members. Upgrade to see it.

SOLV

Price: $86.32

52 week price:
62.38
94.16

Earnings Per Share: 0.88 USD

P/E Ratio: 100.70

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United Kingdom

Market Capitalization: 15.1 billion

Links: